Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Cesca Therapeutics (KOOL) Presents at Rodman & Renshaw Conference

Cesca Therapeutics Inc. (NASDAQ: KOOL) is focused on three target markets: cellular therapeutics; medical/diagnostic device development and commercialization; and cell manufacturing and banking. Cesca’s lead therapeutic technology platform, SurgWerks (an intraoperative rapid system for harvesting, selection/purification, testing, and delivering a therapeutic dose of autologous bone marrow derived or peripheral blood derived cells and proteins), is currently in various stages of clinical trials as a potential treatment for acute myocardial infarction, critical limb ischemia, and orthopedic injuries. For more information, visit the company’s website at

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Comments are closed.